Multinucleation and Mesenchymal-to-Epithelial Transition Alleviate Resistance to Combined Cabazitaxel and Antiandrogen Therapy in Advanced Prostate Cancer
about
Emerging data on androgen receptor splice variants in prostate cancerPterostilbene prevents AKT-ERK axis-mediated polymerization of surface fibronectin on suspended lung cancer cells independently of apoptosis and suppresses metastasis.Multinucleated polyploidy drives resistance to Docetaxel chemotherapy in prostate cancer.TRIM16 suppresses the progression of prostate tumors by inhibiting the Snail signaling pathway.Interplay between Cytoplasmic and Nuclear Androgen Receptor Splice Variants Mediates Castration Resistance.Mechanisms of Therapeutic Resistance in Prostate Cancer.Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer.Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome.Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT.Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells.Predictive value of epithelial-mesenchymal-transition (EMT) signature and PARP-1 in prostate cancer radioresistance.Current treatment strategies for advanced prostate cancer.Aberrant TGF-β Signaling Drives Castration-Resistant Prostate Cancer in a Male Mouse Model of Prostate Tumorigenesis.Profiling Prostate Cancer Therapeutic Resistance.
P2860
Q28077830-46E6B062-121A-4AAF-9D4D-58D983E66FF2Q37715844-8DCB8C22-5F65-4CA6-AFA6-1268A57BA79FQ38710996-D139408A-21A3-41BE-A45B-29453F6399E7Q38740749-C3A4EF94-0A66-41A9-B96E-C0A88D5FB793Q38743584-421F4A06-6C44-41EB-86AC-EF3EFC2BE767Q38754316-1AD0AB49-7187-43EE-854D-41A8A93013D4Q39016544-F7CCEB3A-BA5B-4717-8FA3-A0BB0134F1C2Q39269601-A5CC5AAF-30DB-4F16-A7E9-17366BF63470Q41167484-48FB91B9-8F3B-4719-AABD-5804FE350AADQ47435335-71CEB2E2-27A4-4897-8739-4617F03F9560Q47611805-F11EAEE7-3C16-4EE9-A80B-9F4BB5714765Q48561494-AA93111F-2053-4B79-BF14-0F85D7BDBF7CQ51092129-B4C3B36D-9F0C-4FD7-B83E-AD648E29EDCDQ52644478-9829EEE2-F55E-4711-BC7D-DE7FF7E45873
P2860
Multinucleation and Mesenchymal-to-Epithelial Transition Alleviate Resistance to Combined Cabazitaxel and Antiandrogen Therapy in Advanced Prostate Cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Multinucleation and Mesenchyma ...... py in Advanced Prostate Cancer
@ast
Multinucleation and Mesenchyma ...... py in Advanced Prostate Cancer
@en
type
label
Multinucleation and Mesenchyma ...... py in Advanced Prostate Cancer
@ast
Multinucleation and Mesenchyma ...... py in Advanced Prostate Cancer
@en
prefLabel
Multinucleation and Mesenchyma ...... py in Advanced Prostate Cancer
@ast
Multinucleation and Mesenchyma ...... py in Advanced Prostate Cancer
@en
P2093
P2860
P1433
P1476
Multinucleation and Mesenchyma ...... py in Advanced Prostate Cancer
@en
P2093
Craig Horbinski
Justin C Penticuff
Natasha Kyprianou
Sarah K Martin
P2860
P304
P356
10.1158/0008-5472.CAN-15-2078
P407
P577
2015-12-08T00:00:00Z